Third Harmonic Bio Is A Clinical Stage Biopharmaceutical Company Founded In 2019 By Atlas Venturethe Company Focused On Developing Innovative Treatments For Inflammatory Diseases Affecting The Dermalrespiratoryand Gastrointestinal Systemstheir Lead Product Candidatethb335Was Designed To Address Chronic Spontaneous Urticaria And Other Inflammatory Disorders Through The Inhibition Of Mast Cells As Of April 2025Third Harmonic Bio Announced Plans To Cease Operations And Liquidate Its Assetsfollowing A Thorough Evaluation Of Strategic Optionsthe Decision Aims To Return Funds To Shareholders And Is Pending Shareholder Approvalexpected To Be Finalized By The Third Quarter Of 2025Despite Facing Challenges In Clinical Trialsthe Company Maintained A Strong Financial Position With Cash And Cash Equivalents Totaling $285 1 Million As Of December 312024
No conferences found for this company.
| Company Name | Third Harmonic Bio Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
